177-181 AVENUE PIERRE BROSSOLETTE, MONTROUGE, I0
Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for Filing
DBV Technologies Approves 2026 Performance Share Unit Plan for CEO
Bylaw Amendments Following Shareholder Vote at Annual General Meeting
Annual Report to Security Holders
Reports First Quarter 2026 Financial Results
Financial Results, Press Release
Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting
FY 2025
Q3
Q2
Amended Annual Report
Q1
FY 2024
Notice of Late Filing for Annual Report
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Schedule 13G - Ownership Report
Correspondence
Submission Upload